MedTrace Logo

Testing a Tailored Approach to Long-Term Weight Loss Success

NCT07577765 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-11

No results posted yet for this study

Summary

The purpose of this study is to develop and test an adaptive, individually tailored intervention to prevent weight regain in people who have intentionally lost weight. The main questions it aims to answer are:

* Is an adaptive intervention with tailored re-engagement support feasible for individuals following intentional weight loss?
* Does this intervention prevent weight regain after intentional weight loss?

Participants will:

* Complete a baseline assessment of body measurements
* Complete surveys on dietary intake, mental health, and physical activity

Participants will also engage in a 26-week program, which involves:

* Receive regular educational texts/emails
* Fill out weekly online survey check-ins
* Weigh themselves at least weekly on a scale provided by the study
* Some participants may receive health coaching during portions of the study.
* Assessments will be repeated for all participants at the end of the intervention period.

Conditions

Interventions

BEHAVIORAL

Adaptive weight regain prevention

Adaptive intervention that will tailor participant re-engagement with professional support (e.g. health coaches) based on behavioral triggers and anthropometric monitoring (diet changes, weight increase, failure to weigh weekly).

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Utah

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-07
Primary Completion
2027-09-01
Completion
2027-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07577765 on ClinicalTrials.gov